Cronos Group Inc. (CRON)
NASDAQ: CRON · Real-Time Price · USD
2.555
+0.005 (0.20%)
Aug 27, 2025, 4:00 PM - Market closed
Cronos Group Revenue
Cronos Group had revenue of $33.46M in the quarter ending June 30, 2025, with 20.51% growth. This brings the company's revenue in the last twelve months to $130.28M, up 28.01% year-over-year. In the year 2024, Cronos Group had annual revenue of $117.62M with 34.82% growth.
Revenue (ttm)
$130.28M
Revenue Growth
+28.01%
P/S Ratio
7.50
Revenue / Employee
$283,839
Employees
459
Market Cap
977.62M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 117.62M | 30.37M | 34.82% |
Dec 31, 2023 | 87.24M | 492.00K | 0.57% |
Dec 31, 2022 | 86.75M | 22.19M | 34.37% |
Dec 31, 2021 | 64.56M | 17.84M | 38.19% |
Dec 31, 2020 | 46.72M | 22.97M | 96.71% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 422.82B |
Johnson & Johnson | 90.63B |
Merck & Co. | 63.62B |
AbbVie | 58.33B |
AstraZeneca | 56.50B |
Novartis AG | 55.19B |
Eli Lilly and Company | 53.26B |
Novo Nordisk | 49.11B |
CRON News
- 5 days ago - 3 Top Canadian Marijuana Stocks Impacted By The Cannabis Industry - MarijuanaStocks
- 14 days ago - Top Canadian Marijuana Stocks If Federal Reform Passes In The USA - MarijuanaStocks
- 15 days ago - Cronos Rallies Amidst Greater Cannabis Sector Rally Over Possible Rescheduling - Seeking Alpha
- 16 days ago - Cannabis stocks soar on Trump reclassification speculation - Invezz
- 16 days ago - Cannabis stocks rally on Wall Street Journal report that Trump is weighing drug reclassification - CNBC
- 19 days ago - Cronos Group Inc. (CRON) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 20 days ago - Cronos Group Reports 2025 Second Quarter Results - GlobeNewsWire
- 27 days ago - Top Canadian Pot Stocks Gaining Attention in August 2025 - MarijuanaStocks